Synexus Clinical Research US - Simon Williamson Clinic — Birmingham, Alabama

Synexus Clinical Research US - Simon Williamson Clinic is a clinical research site located in Birmingham, Alabama, United States 35211.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Synexus Clinical Research US - Simon Williamson Clinic has participated in 2 clinical trials.

Therapeutic areas: Irritable Bowel Syndrome, Gastroparesis, Diabetes Mellitus.

Sponsors: Urovant Sciences GmbH, Allergan.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Birmingham

Browse all research sites in Alabama · View every site in Birmingham

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Synexus Clinical Research US - Simon Williamson Clinic?

Synexus Clinical Research US - Simon Williamson Clinic has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Synexus Clinical Research US - Simon Williamson Clinic conducted?

Synexus Clinical Research US - Simon Williamson Clinic has 2 clinical trials on record. Their work covers Irritable Bowel Syndrome, Gastroparesis, Diabetes Mellitus.

Is Synexus Clinical Research US - Simon Williamson Clinic accredited by Crixeo Clinical Trials?

Synexus Clinical Research US - Simon Williamson Clinic has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Synexus Clinical Research US - Simon Williamson Clinic?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.